Anesth Analg 2002;95:1263-1268
© 2002 International Anesthesia Research Society
ANESTHETIC PHARMACOLOGY
The Effects of Lidocaine on the Activity of Glutamate Transporter EAAT3: The Role of Protein Kinase C and Phosphatidylinositol 3-Kinase
Sang-Hwan Do, MD PhD* ,
Hong-yu Fang, MD*,
Byung-Moon Ham, MD PhD , and
Zhiyi Zuo, MD PhD*
*Department of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia; and Department of Anesthesiology, Seoul National University College of Medicine and Clinical Research Laboratory, Seoul, Republic of Korea
Address correspondence and reprint requests to Dr. Zhiyi Zuo, Department of Anesthesiology, University of Virginia, 1 Hospital Dr., PO Box 800710, Charlottesville, VA 229080710. Address e-mail to zz3c{at}virginia.edu
Using two electrode voltage clamps, we investigated the effects of lidocaine on one type of glutamate transporter, EAAT3, and the role of protein kinase C (PKC) and phosphatidylinositol 3-kinase (PI3K) in mediating the lidocaine effects. EAAT3 was expressed in Xenopus oocytes, and membrane currents were recorded after the application of L-glutamate (30 µM). Lidocaine increased glutamate-induced inward currents significantly at 2 concentrations (100 µM and 1 mM), but not at other concentrations. Lidocaine (100 µM) significantly increased the Vmax, but not the Km, of EAAT3 for glutamate compared with control. The action sites of lidocaine on EAAT3 seem to be intracellular, because only intracellularly injected QX314 (permanently charged lidocaine analog) increased the response. The combination of phorbol-12-myrisate-13-acetate, an activator of PKC, and lidocaine did not further increase the responses compared with phorbol-12-myrisate-13-acetate or lidocaine alone, although each of these three groups showed significantly bigger responses than controls. Three PKC inhibitors (staurosporine, calphostin C, and chelerythrine) did not affect the basal EAAT3 activity but abolished lidocaine-enhanced EAAT3 activity. Wortmannin (a specific PI3K inhibitor) inhibited EAAT3 basal activity and lidocaine-enhanced EAAT3 activity. Our results suggest that lidocaine enhances EAAT3 activity at certain concentrations and that PKC and PI3K may mediate these lidocaine effects.
IMPLICATIONS: By using the Xenopus oocyte expression system, we investigated the effects of lidocaine on a glutamate transporter (EAAT3). Our findings suggest that lidocaine enhances EAAT3 activity at certain concentrations and that protein kinase C and phosphatidylinositol 3-kinase may mediate these lidocaine effects.
This article has been cited by other articles:

|
 |

|
 |
 
M. Mertl, H. Daniel, and G. Kottra
Substrate-induced changes in the density of peptide transporter PEPT1 expressed in Xenopus oocytes
Am J Physiol Cell Physiol,
November 1, 2008;
295(5):
C1332 - C1343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hahnenkamp, M. E. Durieux, A. Hahnenkamp, S. K. Schauerte, C. W. Hoenemann, V. Vegh, G. Theilmeier, and M. W. Hollmann
Local anaesthetics inhibit signalling of human NMDA receptors recombinantly expressed in Xenopus laevis oocytes: role of protein kinase C
Br. J. Anaesth.,
January 1, 2006;
96(1):
77 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Zuo and H. Fang
Glutamate transporter type 3 attenuates the activation of N-methy-D-aspartate receptors co-expressed in Xenopus oocytes
J. Exp. Biol.,
June 1, 2005;
208(11):
2063 - 2070.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Hahnenkamp, M. E. Durieux, H. van Aken, S. Berning, T. J. Heyse, C. W. Honemann, and B. Linck
Modulation of Xenopus laevis Ca-Activated Cl Currents by Protein Kinase C and Protein Phosphatases: Implications for Studies of Anesthetic Mechanisms
Anesth. Analg.,
August 1, 2004;
99(2):
416 - 422.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Thomas, W. Zhang, K. Wu, A.-B. Wimmer, B. Gut, G. Wendt-Nordahl, S. Kathofer, V. A.W. Kreye, H. A. Katus, W. Schoels, et al.
Regulation of HERG potassium channel activation by protein kinase C independent of direct phosphorylation of the channel protein
Cardiovasc Res,
July 1, 2003;
59(1):
14 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|